[HTML][HTML] Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

RM Elshazli, EA Toraih, A Elgaml, M El-Mowafy… - PloS one, 2020 - journals.plos.org
Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

[HTML][HTML] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta …

BM Henry, MHS De Oliveira, S Benoit… - Clinical Chemistry and …, 2020 - degruyter.com
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

GV Soraya, ZS Ulhaq - Medicina clinica, 2020 - Elsevier
Introduction and objectives Common laboratory parameters are crucial in aiding coronavirus
disease 2019 (COVID-19) case detection. This study aimed to determine the differences …

[HTML][HTML] Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

D Liao, F Zhou, L Luo, M Xu, H Wang, J Xia… - The Lancet …, 2020 - thelancet.com
Background COVID-19 is an ongoing global pandemic. Changes in haematological
characteristics in patients with COVID-19 are emerging as important features of the disease …

[HTML][HTML] The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

Y Zheng, Y Zhang, H Chi, S Chen, M Peng… - Clinical Chemistry and …, 2020 - degruyter.com
Abstract Objectives In December 2019, there was an outbreak of coronavirus disease 2019
(COVID-19) in Wuhan, China, and since then, the disease has been increasingly spread …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

[HTML][HTML] Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis

B Cao, X Jing, Y Liu, R Wen, C Wang - Journal of Thoracic Disease, 2022 - ncbi.nlm.nih.gov
Background This study aimed to summarize the available data on the association between
the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical …

Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study

SA Mousavi, S Rad, T Rostami, M Rostami… - …, 2020 - Taylor & Francis
Background: The first cases of proved COVID-19 in Iran were reported in February 2020 and
has since rapidly spread worldwide. We aimed to clarify the clinical significance of …

Clinical and laboratory features of COVID-19: Predictors of severe prognosis

A Bastug, H Bodur, S Erdogan, D Gokcinar… - International …, 2020 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) emerged first in December
2019 in Wuhan, China and quickly spread throughout the world. Clinical and laboratory data …

Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID‐19): a multicenter, cross‐sectional study

J Peng, D Qi, G Yuan, X Deng, Y Mei… - Journal of clinical …, 2020 - Wiley Online Library
Background To determine the diagnostic value of hematologic markers for coronavirus
disease 2019 (COVID‐19) and explore their relationship with disease severity. Methods …